Originally published in May 2019, this guideline aims to reduce variation in inhaler prescribing in the management of chronic obstructive pulmonary disease (COPD).
In 2021, this guideline was updated to encourage consideration of the decarbonisation agenda of NHS Wales. This includes recommending the preferential prescribing of Dry Powder Inhalers (DPIs) rather than Metered Dose Inhalers (MDIs) due to the significantly reduced environmental impact associated with their use. This is aligned to the NHS Wales target of reducing the use of MDIs from more than 70% down to less than 20% by 2025 (see NHS Wales Decarbonisation Strategic Delivery Plan). Where appropriate, newly available inhaler options have also been incorporated.
⇩ All Wales COPD Management and Prescribing Guideline 820KB (PDF)